Skip to main content
. 2022 Feb 24;26(2):90–96. doi: 10.7874/jao.2021.00465

Table 3.

Treatment efficacy based on patient questionnaire, broken into primary and secondary treatment medications

Medication Primary treatment
Secondary treatment
n Improved (%) n Improved (%)
Tricyclic antidepressant 11 91 7 57
Topiramate 6 50 1 100
Propranolol 4 80 1 100
Verapamil 4 74 1 0
Gabapentin 1 100 0 0
Botox Injections* 2 100
*

onabotulinumtoxin A injections administered per PHASE III Research Evaluating Migraine Prophylaxis Therapy (PREEMPT) protocol